SlideShare a Scribd company logo
DRUG PRODUCT PERFORMANCE,
IN VITRO
SUBMITTED BY :
ANKIT KUMAR MALIK
SUBMITTED TO :
DR. SANJULA BABOOTA MA’AM
DR. JAVED ALI SIR
DEPARTMENT : Pharmaceutics
School Of Pharmaceutical Education and Research
JAMIA HAMDARD
The solid oral dosage forms should have good quality and better
characteristics for performance. This depends on appropriate
appearance of the product, its potency, its stability and dissolution
of the product.
The characterization of drug product performance, in-vitro is vital
as it provides information about the potency of active ingredients
Drug product performance studies are used in the development of
new and generic drug products.
CONT
D.
This process is also vital as it gives information about the development of
formulation, assessment of comparability, control and assurance of quality.
The characterization of the potency and rate of release by in-vitro testing
in the oral dosage form is based on chapters and monographs mentioned in
the pharmacopoeia of the United States of America.
In-vitro test for the active ingredient to release from the dosage form is
based on:-
Disintegration of product
Dissolution of active ingredient
IN VITRO DISSOLUTION OF DRUG
PRODUCT IS BASED ON FACTORS LIKE:-
1. Drug substance related factors
2. Factors related to formulation
3. Factors related to manufacturing process
4. Factors related to dissolution test apparatus
DRUG SUBSTANCE RELATED
FACTORS
Dissolution refers to the process of solubilization of the drug into the dissolution medium.
Dissolution process is controlled by the affinity between the solid and the dissolution
medium.
Noyes and Whitney in 1897 proposed a fundamental equation for dissolution:-
dm/dt = K X (Cs - Ct)
dm/dt = rate of dissolution
k = proportionality constant or dissolution constant
Cs = concentration at saturation
Ct = concentration at time t
Factors are:-
Drug solubility
Polymorphism
Salt factor
Surface area and particle size
DRUG SOLUBILITY
The drug substance solubility of a drug is related to the dissolution rate of drug.
Higher dissolution rates are given by drugs which have high solubility.
The solubility of compounds containing “ionizable groups” is a function of the pH of
the dissolution media and pKa of the compound.
Solubility of a drug is determined using an equilibrium solubility method and involves
suspending an excess amount of solid drug in selected aqueous medium.
POLYMORPHISM OF DRUG
 When a drug substance :-
existing in two or more crystalline phases that have different arrangement/conformation of the molecule in
the crystal lattice
having different hydrate forms
Having amorphous phases which do not possess a distinguishable crystal lattice
Dissolution rates of drugs having various polymorphic form are effected due to different
lattice energies of the polymorphs which have different solubility.
Crystalline form has less solubility than the amorphous form due to fixed and compact lattice
structure
Example :- Two polymorphic forms of Chloramphenicol palmitate exist which are A and B,
form B is better orally absorbed than form A due to greater solubility.
SALT RELATED FACTORS OF DRUG
Unionizable molecules are less water soluble as compared to the organic
salts which offers a criterion for improving the rate of dissolution.
So, during the development of drug salts of weak bases and
weak acids are chosen .
Example :- The non-steroidal anti-inflammatory drug ‘Naproxen’ was
originally marketed as a free acid for the treatment of rheumatoid or osteo-
arthritis.
FACTORS RELATED TO
FORMULATION
Drug product dissolution is greatly affected by the excepients which are used in the
formulation.
For dosage forms which are for immediate release, those excepients are are used which help in
enhancing the dissolution rate.
Disintegrants like sodium starch glycolate and croscarmellose facilitate the deaggregation and
promote the breakup of tablets into granules.
 The disintegrants effect is to provide an increased surface area of the drug particle and hence
promoting dissolution.
Surfactants can also be included to increase the dissolution rates e.g. sodium lauryl sulphate.
MANUFACTURING PROCESS FACTORS
Several manufacturing variables can affect the drug product dissolution characteristics
so here, manufacturing strategies may be employed to enhance dissolution rates.
For example, spray drying of the active ingredient with excipients such as polyvinyl
pyrrolidine (PVP) can be used to generate stabilized amorphous dispersions, which have
greatly accelerated dissolution rates.
Improved wetting of hydrophobic drug surfaces and enhanced dissolution rates are
sometimes achieved by employing wet granulation vs. dry granulation processes, during
product manufacture.
DISSOLUTION TEST FACTORS
The dissolution test parameters such as:-
Apparatus type
Rotation speed
Dissolution medium pH
Volume
IN VITRO DRUG PRODUCT
PERFORMANCE EVALUATION
Disintegration test :-
It is a qualitative test.
An official disintegration apparatus, the USP basket rack assembly, is used to
perform the test, which is generally applicable only to immediate-release products.
When product dissolution is rapid (defined by ICH as dissolution NLT 80% in 15min
at pH 1.2, 4.0, and 6.8) and the dosage form contains drugs that are highly soluble
throughout the physiological range, disintegration testing may be meaningful.
The ICH Guidance considers a drug substance to be highly soluble when the
highest dose strength is soluble in 250mL or less of aqueous media over the pH
range of 1.2-6.8.
DISINTEGRATION APPARATUS
DISSOLUTION TEST
The test quantitatively measures the amount of active drug that dissolves from the
dosage form in a liquid dissolution medium using standard dissolution apparatus and
procedures.
Apparatus
Apparatus 1 (basket) and 2 (paddle), the apparatus most commonly used for studying the
dissolution of solid oral dosage form. The basket at 100 rpm is commonly used for testing capsules,
and the paddle at 50 rpm for tablets.
Media
The selection of a dissolution test medium is based on the physico-chemical properties of the drug
substance and characteristics of the dosage form.
Media with pH ranging from 1.2 (gastric pH) to 6.8(intestinal pH) are generally preferred.
The most common media used in dissolution testing are water, 0.1N hydrochloric acid, pH 4.5
acetate buffer, and pH 6.8 phosphate buffer.
The temperature of the dissolution bath is usually maintained at 37 0.5C to reflect human body
temperature
.
Tolerance
The dissolution test acceptance criterion, or tolerance, is specified in terms of the quantity (‘‘Q’’)
that is dissolved within a specified time interval.
for most oral dosage forms, 75% or 80% (‘‘Q’’) of the labelled amount of the active drug ingredient
is specified to be dissolved within a set time duration (test times between 15 and 60min are most
common).
DISSOLUTION TESTER
APPLICATIONS OF IN VITRO
DISSOLUTION
Product Development
In vitro dissolution is an important and useful tool during the development of a
dosage form. In vitro dissolution often aids in guiding the selection of prototype
formulations and for determining optimum levels of ingredients to achieve drug
release profiles.
Product Stability
In vitro dissolution is also used to assess drug product quality with respect to
stability and shelf life.
As products age, physicochemical changes to the dosage form may alter the
dissolution characteristics of the drug product over time.
For example, as the moisture level increases or decreases over time, this can result
in altered tablet hardness and subsequent possible changes in dissolution
characteristics.
.
THANK YOU

More Related Content

What's hot

Mechanism of dds1
Mechanism of dds1Mechanism of dds1
Mechanism of dds1
Sachin G
 
GLOBAL SUBMISSION OF IND-1.pptx
GLOBAL SUBMISSION OF IND-1.pptxGLOBAL SUBMISSION OF IND-1.pptx
GLOBAL SUBMISSION OF IND-1.pptx
MrRajanSwamiSwami
 
Sr or cr formulations
Sr or cr formulationsSr or cr formulations
Sr or cr formulations
Pratiksha Chandragirivar
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
Himal Barakoti
 
Enzyme activated drug delivery systems
Enzyme activated drug delivery systemsEnzyme activated drug delivery systems
Enzyme activated drug delivery systems
Mehak AggarwAl
 
Study of consolidation parameters.pptx
Study of consolidation parameters.pptxStudy of consolidation parameters.pptx
Study of consolidation parameters.pptx
PawanDhamala1
 
Rate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemRate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery System
Kailas Mali
 
Sustained and controlled release drug delivery system
Sustained and controlled release drug delivery systemSustained and controlled release drug delivery system
Sustained and controlled release drug delivery system
Parul Sharma
 
Compaction profiles
Compaction profilesCompaction profiles
Compaction profiles
Siddu K M
 
API, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptxAPI, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptx
PawanDhamala1
 
Industry and fda liaison
Industry and fda liaisonIndustry and fda liaison
Industry and fda liaison
Bashant Kumar sah
 
Consolidation, effect of friction, distribution of forces, compaction profile
Consolidation, effect of friction, distribution of forces, compaction profileConsolidation, effect of friction, distribution of forces, compaction profile
Consolidation, effect of friction, distribution of forces, compaction profile
Zahid1392
 
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxDIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
Kailas Mali
 
Cmc, post approval and regulation
Cmc, post approval and regulationCmc, post approval and regulation
Cmc, post approval and regulation
Himal Barakoti
 
Single shot vaccines Naveen Balaji
Single shot vaccines Naveen BalajiSingle shot vaccines Naveen Balaji
Single shot vaccines Naveen Balaji
Naveen Balaji
 
CMC, post approval regulatory affairs, etc
CMC, post approval regulatory affairs, etcCMC, post approval regulatory affairs, etc
CMC, post approval regulatory affairs, etc
JayeshRajput7
 
Mechanical and pH activated DDS.pptx
Mechanical and pH activated DDS.pptxMechanical and pH activated DDS.pptx
Mechanical and pH activated DDS.pptx
PawanDhamala1
 
Theories of dispersion
Theories of dispersionTheories of dispersion
Theories of dispersion
Rahul Krishnan
 
Drug product perfomance in vitro
Drug product perfomance in vitroDrug product perfomance in vitro
Drug product perfomance in vitro
S.N.A.Institute of Pharmacy- Haidergarh,Barabanki
 
Evaluation of protein & peptide dds
Evaluation of protein & peptide ddsEvaluation of protein & peptide dds
Evaluation of protein & peptide dds
Māľāý Păųļ
 

What's hot (20)

Mechanism of dds1
Mechanism of dds1Mechanism of dds1
Mechanism of dds1
 
GLOBAL SUBMISSION OF IND-1.pptx
GLOBAL SUBMISSION OF IND-1.pptxGLOBAL SUBMISSION OF IND-1.pptx
GLOBAL SUBMISSION OF IND-1.pptx
 
Sr or cr formulations
Sr or cr formulationsSr or cr formulations
Sr or cr formulations
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
 
Enzyme activated drug delivery systems
Enzyme activated drug delivery systemsEnzyme activated drug delivery systems
Enzyme activated drug delivery systems
 
Study of consolidation parameters.pptx
Study of consolidation parameters.pptxStudy of consolidation parameters.pptx
Study of consolidation parameters.pptx
 
Rate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery SystemRate-Controlled Drug Delivery System
Rate-Controlled Drug Delivery System
 
Sustained and controlled release drug delivery system
Sustained and controlled release drug delivery systemSustained and controlled release drug delivery system
Sustained and controlled release drug delivery system
 
Compaction profiles
Compaction profilesCompaction profiles
Compaction profiles
 
API, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptxAPI, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptx
 
Industry and fda liaison
Industry and fda liaisonIndustry and fda liaison
Industry and fda liaison
 
Consolidation, effect of friction, distribution of forces, compaction profile
Consolidation, effect of friction, distribution of forces, compaction profileConsolidation, effect of friction, distribution of forces, compaction profile
Consolidation, effect of friction, distribution of forces, compaction profile
 
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxDIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
 
Cmc, post approval and regulation
Cmc, post approval and regulationCmc, post approval and regulation
Cmc, post approval and regulation
 
Single shot vaccines Naveen Balaji
Single shot vaccines Naveen BalajiSingle shot vaccines Naveen Balaji
Single shot vaccines Naveen Balaji
 
CMC, post approval regulatory affairs, etc
CMC, post approval regulatory affairs, etcCMC, post approval regulatory affairs, etc
CMC, post approval regulatory affairs, etc
 
Mechanical and pH activated DDS.pptx
Mechanical and pH activated DDS.pptxMechanical and pH activated DDS.pptx
Mechanical and pH activated DDS.pptx
 
Theories of dispersion
Theories of dispersionTheories of dispersion
Theories of dispersion
 
Drug product perfomance in vitro
Drug product perfomance in vitroDrug product perfomance in vitro
Drug product perfomance in vitro
 
Evaluation of protein & peptide dds
Evaluation of protein & peptide ddsEvaluation of protein & peptide dds
Evaluation of protein & peptide dds
 

Similar to DRUG PRODUCT PERFORMANCE, IN VITRO

Drug product performance (joel)
Drug product performance (joel)Drug product performance (joel)
Drug product performance (joel)
PradheepPradheep2
 
Prodact performance in vitro.pptx
Prodact performance in vitro.pptxProdact performance in vitro.pptx
Prodact performance in vitro.pptx
Dnyaneshwar Ningule
 
Preformulation
PreformulationPreformulation
Preformulation
Protik Biswas
 
The role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceThe role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalence
inemet
 
Disolution best
Disolution bestDisolution best
Preformulation Guide
Preformulation GuidePreformulation Guide
Preformulation Guide
Vijayendrakumar
 
Dissolution -final
Dissolution  -finalDissolution  -final
Dissolution -final
Pushpendu Gaurav
 
Preformulation and product development
Preformulation and product developmentPreformulation and product development
Preformulation and product development
Bishnu Koirala
 
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptxPREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
SWASTIKPATNAIK1
 
Preformulation guide
Preformulation guidePreformulation guide
Preformulation guideRitul Shah
 
Biopharmaceutic considerations in drug product design and in
Biopharmaceutic considerations in drug product design and inBiopharmaceutic considerations in drug product design and in
Biopharmaceutic considerations in drug product design and in
SUJITHA MARY
 
Dissolution Test development in regard to bioequivalence
Dissolution Test development in regard to bioequivalenceDissolution Test development in regard to bioequivalence
Dissolution Test development in regard to bioequivalenceanezlin
 
Pfs
PfsPfs
Stability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.pptStability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.ppt
Ravi Kumar G
 
Claim & Reasonable Probability (Part 2)
Claim & Reasonable Probability (Part 2)Claim & Reasonable Probability (Part 2)
Claim & Reasonable Probability (Part 2)
Obaid Ali / Roohi B. Obaid
 
validation of disso method 2.pdf
validation of disso method  2.pdfvalidation of disso method  2.pdf
validation of disso method 2.pdf
ManivannanKathirvel1
 
Dissolution_Technique.ppt
Dissolution_Technique.pptDissolution_Technique.ppt
Dissolution_Technique.ppt
Ravi Kumar G
 
Stability studies of drugs
Stability studies of drugsStability studies of drugs
Stability studies of drugs
Muhammed hamed albuissa
 
Bioavailability and bioequivalence study
Bioavailability and bioequivalence studyBioavailability and bioequivalence study
Bioavailability and bioequivalence study
Mcpl Moshi
 

Similar to DRUG PRODUCT PERFORMANCE, IN VITRO (20)

Drug product performance (joel)
Drug product performance (joel)Drug product performance (joel)
Drug product performance (joel)
 
Prodact performance in vitro.pptx
Prodact performance in vitro.pptxProdact performance in vitro.pptx
Prodact performance in vitro.pptx
 
Preformulation
PreformulationPreformulation
Preformulation
 
The role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceThe role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalence
 
Disolution best
Disolution bestDisolution best
Disolution best
 
Preformulation Guide
Preformulation GuidePreformulation Guide
Preformulation Guide
 
Dissolution -final
Dissolution  -finalDissolution  -final
Dissolution -final
 
Preformulation and product development
Preformulation and product developmentPreformulation and product development
Preformulation and product development
 
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptxPREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
PREFORMULATION STUDY IN DESIGNING OF TABLET DOSAGES FORM.pptx
 
Seminar on Dissolution Media
Seminar on Dissolution MediaSeminar on Dissolution Media
Seminar on Dissolution Media
 
Preformulation guide
Preformulation guidePreformulation guide
Preformulation guide
 
Biopharmaceutic considerations in drug product design and in
Biopharmaceutic considerations in drug product design and inBiopharmaceutic considerations in drug product design and in
Biopharmaceutic considerations in drug product design and in
 
Dissolution Test development in regard to bioequivalence
Dissolution Test development in regard to bioequivalenceDissolution Test development in regard to bioequivalence
Dissolution Test development in regard to bioequivalence
 
Pfs
PfsPfs
Pfs
 
Stability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.pptStability_Considerations_In_Formulation_Development.ppt
Stability_Considerations_In_Formulation_Development.ppt
 
Claim & Reasonable Probability (Part 2)
Claim & Reasonable Probability (Part 2)Claim & Reasonable Probability (Part 2)
Claim & Reasonable Probability (Part 2)
 
validation of disso method 2.pdf
validation of disso method  2.pdfvalidation of disso method  2.pdf
validation of disso method 2.pdf
 
Dissolution_Technique.ppt
Dissolution_Technique.pptDissolution_Technique.ppt
Dissolution_Technique.ppt
 
Stability studies of drugs
Stability studies of drugsStability studies of drugs
Stability studies of drugs
 
Bioavailability and bioequivalence study
Bioavailability and bioequivalence studyBioavailability and bioequivalence study
Bioavailability and bioequivalence study
 

More from Ankit Malik

Ankit chrono pharmacology
Ankit chrono pharmacologyAnkit chrono pharmacology
Ankit chrono pharmacology
Ankit Malik
 
Problems associated with oral cavity
Problems associated with oral cavityProblems associated with oral cavity
Problems associated with oral cavity
Ankit Malik
 
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
Ankit Malik
 
Ankit lipid dds
Ankit lipid ddsAnkit lipid dds
Ankit lipid dds
Ankit Malik
 
Bioelectronic medicines
Bioelectronic medicinesBioelectronic medicines
Bioelectronic medicines
Ankit Malik
 
Kinetics of stability and stability testing
Kinetics of stability and stability testingKinetics of stability and stability testing
Kinetics of stability and stability testing
Ankit Malik
 
Ankit gastro retentive drug delivery system
Ankit gastro retentive drug delivery systemAnkit gastro retentive drug delivery system
Ankit gastro retentive drug delivery system
Ankit Malik
 
Cfr ankit
Cfr  ankitCfr  ankit
Cfr ankit
Ankit Malik
 
CODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS CODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS
Ankit Malik
 

More from Ankit Malik (9)

Ankit chrono pharmacology
Ankit chrono pharmacologyAnkit chrono pharmacology
Ankit chrono pharmacology
 
Problems associated with oral cavity
Problems associated with oral cavityProblems associated with oral cavity
Problems associated with oral cavity
 
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
 
Ankit lipid dds
Ankit lipid ddsAnkit lipid dds
Ankit lipid dds
 
Bioelectronic medicines
Bioelectronic medicinesBioelectronic medicines
Bioelectronic medicines
 
Kinetics of stability and stability testing
Kinetics of stability and stability testingKinetics of stability and stability testing
Kinetics of stability and stability testing
 
Ankit gastro retentive drug delivery system
Ankit gastro retentive drug delivery systemAnkit gastro retentive drug delivery system
Ankit gastro retentive drug delivery system
 
Cfr ankit
Cfr  ankitCfr  ankit
Cfr ankit
 
CODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS CODE OF FEDERAL REGULATIONS
CODE OF FEDERAL REGULATIONS
 

Recently uploaded

Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 

Recently uploaded (20)

Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 

DRUG PRODUCT PERFORMANCE, IN VITRO

  • 1. DRUG PRODUCT PERFORMANCE, IN VITRO SUBMITTED BY : ANKIT KUMAR MALIK SUBMITTED TO : DR. SANJULA BABOOTA MA’AM DR. JAVED ALI SIR DEPARTMENT : Pharmaceutics School Of Pharmaceutical Education and Research JAMIA HAMDARD
  • 2. The solid oral dosage forms should have good quality and better characteristics for performance. This depends on appropriate appearance of the product, its potency, its stability and dissolution of the product. The characterization of drug product performance, in-vitro is vital as it provides information about the potency of active ingredients Drug product performance studies are used in the development of new and generic drug products.
  • 3. CONT D. This process is also vital as it gives information about the development of formulation, assessment of comparability, control and assurance of quality. The characterization of the potency and rate of release by in-vitro testing in the oral dosage form is based on chapters and monographs mentioned in the pharmacopoeia of the United States of America. In-vitro test for the active ingredient to release from the dosage form is based on:- Disintegration of product Dissolution of active ingredient
  • 4. IN VITRO DISSOLUTION OF DRUG PRODUCT IS BASED ON FACTORS LIKE:- 1. Drug substance related factors 2. Factors related to formulation 3. Factors related to manufacturing process 4. Factors related to dissolution test apparatus
  • 5. DRUG SUBSTANCE RELATED FACTORS Dissolution refers to the process of solubilization of the drug into the dissolution medium. Dissolution process is controlled by the affinity between the solid and the dissolution medium. Noyes and Whitney in 1897 proposed a fundamental equation for dissolution:- dm/dt = K X (Cs - Ct) dm/dt = rate of dissolution k = proportionality constant or dissolution constant Cs = concentration at saturation Ct = concentration at time t Factors are:- Drug solubility Polymorphism Salt factor Surface area and particle size
  • 6. DRUG SOLUBILITY The drug substance solubility of a drug is related to the dissolution rate of drug. Higher dissolution rates are given by drugs which have high solubility. The solubility of compounds containing “ionizable groups” is a function of the pH of the dissolution media and pKa of the compound. Solubility of a drug is determined using an equilibrium solubility method and involves suspending an excess amount of solid drug in selected aqueous medium.
  • 7. POLYMORPHISM OF DRUG  When a drug substance :- existing in two or more crystalline phases that have different arrangement/conformation of the molecule in the crystal lattice having different hydrate forms Having amorphous phases which do not possess a distinguishable crystal lattice Dissolution rates of drugs having various polymorphic form are effected due to different lattice energies of the polymorphs which have different solubility. Crystalline form has less solubility than the amorphous form due to fixed and compact lattice structure Example :- Two polymorphic forms of Chloramphenicol palmitate exist which are A and B, form B is better orally absorbed than form A due to greater solubility.
  • 8. SALT RELATED FACTORS OF DRUG Unionizable molecules are less water soluble as compared to the organic salts which offers a criterion for improving the rate of dissolution. So, during the development of drug salts of weak bases and weak acids are chosen . Example :- The non-steroidal anti-inflammatory drug ‘Naproxen’ was originally marketed as a free acid for the treatment of rheumatoid or osteo- arthritis.
  • 9. FACTORS RELATED TO FORMULATION Drug product dissolution is greatly affected by the excepients which are used in the formulation. For dosage forms which are for immediate release, those excepients are are used which help in enhancing the dissolution rate. Disintegrants like sodium starch glycolate and croscarmellose facilitate the deaggregation and promote the breakup of tablets into granules.  The disintegrants effect is to provide an increased surface area of the drug particle and hence promoting dissolution. Surfactants can also be included to increase the dissolution rates e.g. sodium lauryl sulphate.
  • 10. MANUFACTURING PROCESS FACTORS Several manufacturing variables can affect the drug product dissolution characteristics so here, manufacturing strategies may be employed to enhance dissolution rates. For example, spray drying of the active ingredient with excipients such as polyvinyl pyrrolidine (PVP) can be used to generate stabilized amorphous dispersions, which have greatly accelerated dissolution rates. Improved wetting of hydrophobic drug surfaces and enhanced dissolution rates are sometimes achieved by employing wet granulation vs. dry granulation processes, during product manufacture.
  • 11. DISSOLUTION TEST FACTORS The dissolution test parameters such as:- Apparatus type Rotation speed Dissolution medium pH Volume
  • 12. IN VITRO DRUG PRODUCT PERFORMANCE EVALUATION Disintegration test :- It is a qualitative test. An official disintegration apparatus, the USP basket rack assembly, is used to perform the test, which is generally applicable only to immediate-release products. When product dissolution is rapid (defined by ICH as dissolution NLT 80% in 15min at pH 1.2, 4.0, and 6.8) and the dosage form contains drugs that are highly soluble throughout the physiological range, disintegration testing may be meaningful. The ICH Guidance considers a drug substance to be highly soluble when the highest dose strength is soluble in 250mL or less of aqueous media over the pH range of 1.2-6.8.
  • 14. DISSOLUTION TEST The test quantitatively measures the amount of active drug that dissolves from the dosage form in a liquid dissolution medium using standard dissolution apparatus and procedures. Apparatus Apparatus 1 (basket) and 2 (paddle), the apparatus most commonly used for studying the dissolution of solid oral dosage form. The basket at 100 rpm is commonly used for testing capsules, and the paddle at 50 rpm for tablets. Media The selection of a dissolution test medium is based on the physico-chemical properties of the drug substance and characteristics of the dosage form. Media with pH ranging from 1.2 (gastric pH) to 6.8(intestinal pH) are generally preferred. The most common media used in dissolution testing are water, 0.1N hydrochloric acid, pH 4.5 acetate buffer, and pH 6.8 phosphate buffer. The temperature of the dissolution bath is usually maintained at 37 0.5C to reflect human body temperature
  • 15. . Tolerance The dissolution test acceptance criterion, or tolerance, is specified in terms of the quantity (‘‘Q’’) that is dissolved within a specified time interval. for most oral dosage forms, 75% or 80% (‘‘Q’’) of the labelled amount of the active drug ingredient is specified to be dissolved within a set time duration (test times between 15 and 60min are most common).
  • 17. APPLICATIONS OF IN VITRO DISSOLUTION Product Development In vitro dissolution is an important and useful tool during the development of a dosage form. In vitro dissolution often aids in guiding the selection of prototype formulations and for determining optimum levels of ingredients to achieve drug release profiles. Product Stability In vitro dissolution is also used to assess drug product quality with respect to stability and shelf life. As products age, physicochemical changes to the dosage form may alter the dissolution characteristics of the drug product over time. For example, as the moisture level increases or decreases over time, this can result in altered tablet hardness and subsequent possible changes in dissolution characteristics.